SCHEMBL4190458

SCHEMBL4190458

C=C(C)C(=O)OC(COc1cccc(OCC(COc2ccc3ccccc3c2)OC(=O)C(=C)C)c1)COc1ccc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 1/20 0.44
RAB9A P51151 4/20 0.42
MAPK1 P28482 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
PPARG P37231 1/20 0.41
KMT2A Q03164 1/20 0.41
NCOA2 Q15596 1/20 0.41
NCOA1 Q15788 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR2E3 Q9Y5X4 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
KDM1A O60341 1/20 0.41
RECQL P46063 1/20 0.41
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193366 0.95 PTPN7 (0.47) PTPN7RAB9AMAPK1ALDH1A1KDM4E
SCHEMBL4204699 0.91 PTPN7 (0.43) PTPN7RAB9AMAPK1ALDH1A1KDM4E
SCHEMBL4198425 0.91 PTPN7 (0.43) PTPN7RAB9AMAPK1ALDH1A1KDM4E
SCHEMBL11957216 0.89 MTNR1A (0.46) MAPK1MTNR1AMTNR1BLMNAPOLB
SCHEMBL25123427 0.89 RAB9A (0.42) PTPN7RAB9AMAPK1ALDH1A1KDM4E
SCHEMBL4196017 0.88 PTPN7 (0.41) PTPN7RAB9AMAPK1ALDH1A1KDM4E
SCHEMBL4184734 0.86 MAPT (0.45) MAPK1MTNR1AMTNR1BLMNA
SCHEMBL4198600 0.86 MAPK1 (0.40) PTPN7RAB9AMAPK1ALDH1A1KDM4E
SCHEMBL4190889 0.85 MEN1 (0.43) PTPN7MAPK1ALDH1A1KDM4EMEN1
SCHEMBL4194783 0.85 CYP1A2 (0.44) MAPK1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 PTPN7 4180/4885RAB9A 2207/4885MAPK1 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.